Search

Aim To report the long-term visual outcome of a multicentre prospectively recruited cohort of macula-off rhegmatogenous retinal detachments (RRD) Methods The Scottish retinal detachment study was a prospectively recruited study that recruited all incident cases of primary RRD in Scotland over a 2-year period (2007-2009). All patients with a macula-off RRD from four participating sites were invited for clinical examination at 6 weeks, 3 months, 6 months and 1 year after the initial surgery. Using a joinpoint model we estimated the effect of duration of macular detachment on final visual outcome. Results In total, there were 291 patients with maculaoff RRD without pre-existing retinal disease who had successful repair after one operation. 65.9% achieved a final visual acuity (VA) of 0.48 logMAR(6/18). Our model identified two time points (day 8 (95% CI 3 to 15 days) and (day 21 (95% CI 6 to 26 days)) after which there was a statistically significant worsening in final VA. Conclusions Our study suggests that the majority of patients with macula-off RRD successfully repaired with one operation will achieve a VA of 6/18 or better at final follow-up. After 8 days of macular detachment, the final visual outcome may be adversely affected and, thus, operative repair within this period is desirable. Duration of macular detachment of Ͱ8 days demonstrated a continuing improvement in VA for up to 1 year, a finding which was not found in macula detachments of longer duration. [ABSTRACT FROM AUTHOR]

Purpose: Trends in antibiotic sensitivity of pathogenic bacteria change with time and the emergence of resistance to commonly used antibiotics is not uncommon. The aim of this study is to identify the antibiotic susceptibility and resistance patterns in a tertiary referral centre that commonly manages corneal infections. Methods: This is a retrospective review of microbiology reports of corneal scrapes in a tertiary care hospital. Results: There were 205 positive corneal scrapes (32 per cent) in 1995 to 1998 and 147 (28 per cent) in 2004 to 2007. There was increased incidence of Staphylococcus aureus (18 to 21 per cent) (p = 0.16), Moraxella catarrhalis (1.5 to 5 per cent) (p = 0.5), pseudomonas species (6 to 14.5 per cent) (p = 0.25) and non-lactose fermenting coliforms (1.5 to 7 per cent) (p = 0.5). In vitro resistance of gram-positive bacterial isolates to ciprofloxacin was increased from 5 to 7 per cent (p = 0.5). The in vitro susceptibility of gram-positive organisms to dual therapy with cefuroxime and gentamicin were 98 per cent in 1995 to 1998, and 94 per cent in 2004 to 2007 (p = 0.1). Pseudomonas species were 100 per cent susceptible to cefuroxime in the first period but developed 100 per cent resistance in the later period (p = 0.0002). However, the susceptibility of gram negative bacterial isolates to dual therapy with cefuroxime and gentamicin (p = 1) and monotherapy with ciprofloxacin (p = 1) was 100 per cent in both periods. The in vitro resistance to chloramphenicol to gram-positive organisms was reduced to 5 from 12 per cent (p = 0.19) but there was an increase in resistance of gram-negative organisms from 23 to 36 per cent (p = 0.3). Conclusion: Despite limitations, this study demonstrates that the fortified antibiotics such as 5% cefuroxime 1.5% gentamicin may be the appropriate choices for most episodes of bacterial keratitis, either as an initial therapy or after identification of in vitro susceptibility of bacterial isolates. [ABSTRACT FROM AUTHOR]